Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post –Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response—A Single-Center Study
Patients after liver transplantation (LT) with hepatitis C virus (HCV) infection often suffer from renal or hepatic impairment. Treating patients after LT with direct-acting antivirals (DAA) might result in decreasing renal function due to interaction of DAA and immunosuppressive therapy. In this single-center study we analyzed clinical parameters of 18 HCV-infected patients treated with DAA therapy after LT.
Source: Transplantation Proceedings - Category: Transplant Surgery Authors: G. Peschel, L. Moleda, L. Baier, M. Selgrad, S. Schmid, M.N. Scherer, M. M üller, K. Weigand Tags: Milestones in Transplantation Source Type: research
More News: Antiviral Therapy | Hepatitis | Hepatitis C | Liver | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology | Virology